In Ischemic Heart Disease, Reduced Sensitivity to Pressure at the Sternum Accompanies Lower Mortality after Five Years: Evidence from a Randomized Controlled Trial

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

In Ischemic Heart Disease, Reduced Sensitivity to Pressure at the Sternum Accompanies Lower Mortality after Five Years : Evidence from a Randomized Controlled Trial. / Ballegaard, Søren; Faber, Jens; Selmer, Christian; Gyntelberg, Finn; Kreiner, Svend; Karpatschof, Benny; Klausen, Tobias Wirenfeldt; Hjalmarson, Åke; Gjedde, Albert.

I: Journal of Clinical Medicine, Bind 12, Nr. 24, 7585, 2023.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Ballegaard, S, Faber, J, Selmer, C, Gyntelberg, F, Kreiner, S, Karpatschof, B, Klausen, TW, Hjalmarson, Å & Gjedde, A 2023, 'In Ischemic Heart Disease, Reduced Sensitivity to Pressure at the Sternum Accompanies Lower Mortality after Five Years: Evidence from a Randomized Controlled Trial', Journal of Clinical Medicine, bind 12, nr. 24, 7585. https://doi.org/10.3390/jcm12247585

APA

Ballegaard, S., Faber, J., Selmer, C., Gyntelberg, F., Kreiner, S., Karpatschof, B., Klausen, T. W., Hjalmarson, Å., & Gjedde, A. (2023). In Ischemic Heart Disease, Reduced Sensitivity to Pressure at the Sternum Accompanies Lower Mortality after Five Years: Evidence from a Randomized Controlled Trial. Journal of Clinical Medicine, 12(24), [7585]. https://doi.org/10.3390/jcm12247585

Vancouver

Ballegaard S, Faber J, Selmer C, Gyntelberg F, Kreiner S, Karpatschof B o.a. In Ischemic Heart Disease, Reduced Sensitivity to Pressure at the Sternum Accompanies Lower Mortality after Five Years: Evidence from a Randomized Controlled Trial. Journal of Clinical Medicine. 2023;12(24). 7585. https://doi.org/10.3390/jcm12247585

Author

Ballegaard, Søren ; Faber, Jens ; Selmer, Christian ; Gyntelberg, Finn ; Kreiner, Svend ; Karpatschof, Benny ; Klausen, Tobias Wirenfeldt ; Hjalmarson, Åke ; Gjedde, Albert. / In Ischemic Heart Disease, Reduced Sensitivity to Pressure at the Sternum Accompanies Lower Mortality after Five Years : Evidence from a Randomized Controlled Trial. I: Journal of Clinical Medicine. 2023 ; Bind 12, Nr. 24.

Bibtex

@article{385a39a8593c49458b181cf030c20818,
title = "In Ischemic Heart Disease, Reduced Sensitivity to Pressure at the Sternum Accompanies Lower Mortality after Five Years: Evidence from a Randomized Controlled Trial",
abstract = "Background: Autonomic nervous system dysfunction (ANSD) is associated with negative prognosis of ischemic heart disease (IHD). Elevated periosteal pressure sensitivity (PPS) at the sternum relates to ANSD and sympathetic hyperactivity. Two previous observational case–control studies of the effect of reduction of PPS suggested lower all-cause mortality from IHD and stroke. We now used a specific daily, adjunct, non-pharmacological program of reduction of elevated PPS to test the hypothetical association between the intervention and reduced all-cause mortality in patients with stable IHD in a randomized controlled trial (RCT). Methods: We completed active (n = 106) and passive interventions (n = 107) and compared the five-year mortalities. We also compared the five-year individual all-cause mortality of each participant to approximately 35.000 members of the general population of Denmark. Pooling the mortality data from the active group of the RCT with the two preliminary studies, we registered the mortality following active intervention of 1.168 person-years, compared to 40 million person-years of the pooled general population. Results: We recorded fewer deaths of the active RCT intervention group than of the corresponding control group from the general population (p = 0.01), as well as of the passive RCT intervention group (p = 0.035). The meta-analysis of the three studies together demonstrated reduced 4.2-year all-cause mortality of 60% (p = 0.007). Conclusions: The test of the hypothetical effect of an intervention aimed at the attenuation of ANSD accompanied by a lowered PPS revealed reduced all-cause mortality in patients with stable IHD.",
keywords = "autonomic nervous system, autonomic nervous system dysfunction, ischemic heart disease, mortality, periosteal pressure sensitivity, sympathetic hyperactivity",
author = "S{\o}ren Ballegaard and Jens Faber and Christian Selmer and Finn Gyntelberg and Svend Kreiner and Benny Karpatschof and Klausen, {Tobias Wirenfeldt} and {\AA}ke Hjalmarson and Albert Gjedde",
note = "Publisher Copyright: {\textcopyright} 2023 by the authors.",
year = "2023",
doi = "10.3390/jcm12247585",
language = "English",
volume = "12",
journal = "Journal of Clinical Medicine",
issn = "2077-0383",
publisher = "M D P I AG",
number = "24",

}

RIS

TY - JOUR

T1 - In Ischemic Heart Disease, Reduced Sensitivity to Pressure at the Sternum Accompanies Lower Mortality after Five Years

T2 - Evidence from a Randomized Controlled Trial

AU - Ballegaard, Søren

AU - Faber, Jens

AU - Selmer, Christian

AU - Gyntelberg, Finn

AU - Kreiner, Svend

AU - Karpatschof, Benny

AU - Klausen, Tobias Wirenfeldt

AU - Hjalmarson, Åke

AU - Gjedde, Albert

N1 - Publisher Copyright: © 2023 by the authors.

PY - 2023

Y1 - 2023

N2 - Background: Autonomic nervous system dysfunction (ANSD) is associated with negative prognosis of ischemic heart disease (IHD). Elevated periosteal pressure sensitivity (PPS) at the sternum relates to ANSD and sympathetic hyperactivity. Two previous observational case–control studies of the effect of reduction of PPS suggested lower all-cause mortality from IHD and stroke. We now used a specific daily, adjunct, non-pharmacological program of reduction of elevated PPS to test the hypothetical association between the intervention and reduced all-cause mortality in patients with stable IHD in a randomized controlled trial (RCT). Methods: We completed active (n = 106) and passive interventions (n = 107) and compared the five-year mortalities. We also compared the five-year individual all-cause mortality of each participant to approximately 35.000 members of the general population of Denmark. Pooling the mortality data from the active group of the RCT with the two preliminary studies, we registered the mortality following active intervention of 1.168 person-years, compared to 40 million person-years of the pooled general population. Results: We recorded fewer deaths of the active RCT intervention group than of the corresponding control group from the general population (p = 0.01), as well as of the passive RCT intervention group (p = 0.035). The meta-analysis of the three studies together demonstrated reduced 4.2-year all-cause mortality of 60% (p = 0.007). Conclusions: The test of the hypothetical effect of an intervention aimed at the attenuation of ANSD accompanied by a lowered PPS revealed reduced all-cause mortality in patients with stable IHD.

AB - Background: Autonomic nervous system dysfunction (ANSD) is associated with negative prognosis of ischemic heart disease (IHD). Elevated periosteal pressure sensitivity (PPS) at the sternum relates to ANSD and sympathetic hyperactivity. Two previous observational case–control studies of the effect of reduction of PPS suggested lower all-cause mortality from IHD and stroke. We now used a specific daily, adjunct, non-pharmacological program of reduction of elevated PPS to test the hypothetical association between the intervention and reduced all-cause mortality in patients with stable IHD in a randomized controlled trial (RCT). Methods: We completed active (n = 106) and passive interventions (n = 107) and compared the five-year mortalities. We also compared the five-year individual all-cause mortality of each participant to approximately 35.000 members of the general population of Denmark. Pooling the mortality data from the active group of the RCT with the two preliminary studies, we registered the mortality following active intervention of 1.168 person-years, compared to 40 million person-years of the pooled general population. Results: We recorded fewer deaths of the active RCT intervention group than of the corresponding control group from the general population (p = 0.01), as well as of the passive RCT intervention group (p = 0.035). The meta-analysis of the three studies together demonstrated reduced 4.2-year all-cause mortality of 60% (p = 0.007). Conclusions: The test of the hypothetical effect of an intervention aimed at the attenuation of ANSD accompanied by a lowered PPS revealed reduced all-cause mortality in patients with stable IHD.

KW - autonomic nervous system

KW - autonomic nervous system dysfunction

KW - ischemic heart disease

KW - mortality

KW - periosteal pressure sensitivity

KW - sympathetic hyperactivity

U2 - 10.3390/jcm12247585

DO - 10.3390/jcm12247585

M3 - Journal article

C2 - 38137654

AN - SCOPUS:85180656734

VL - 12

JO - Journal of Clinical Medicine

JF - Journal of Clinical Medicine

SN - 2077-0383

IS - 24

M1 - 7585

ER -

ID: 379254780